Bio-reference Labs, Inc. (BRLI) Misses Q1 EPS by 8c (Earlier)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Tech stocks power S&P 500 to record high as oil prices, producer inflation ease
- Oil falls more than 3% on weaker global demand outlook and US crude buildup
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Bio-Reference Laboratories, Inc. Reports Over 15% Increase in Revenue; Net Income Up Over 100%, Year Over Year
March 5, 2015 8:30 AM ESTELMWOOD PARK, N.J., March 5, 2015 (GLOBE NEWSWIRE) -- Bio-Reference Laboratories, Inc. (Nasdaq: BRLI) announces first quarter results. Except for per share data or where otherwise noted, numbers are in thousands.
The Company recorded Q1FY15 revenues of $208,833, an increase of 15% over the $181,270 recorded in Q1FY14. Net income before taxes in Q1FY15 totaled $11,504, an increase of 119% compared with net income before taxes of $5,255 in Q1FY14. Net income after tax for Q1FY15 totaled $6,633, or $.24 per share, as compared with $2,954, or $.11 per share, in Q1FY14. The Company noted in Q1FY14... More
